Hykes Andrew's Form 4 filing
Inari Medical, Inc. (NARI) · filed Nov 17, 2023
- Accession no.
- 0001127602-23-027915
- Filed
- Nov 17, 2023
- Trade date
- Nov 16, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $2.24M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hykes AndrewCIK 0001806431 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 16, 2023 | Common Stock | SSaleDisposed | −21,033 | $59.53 | −$1,252,094.49 | 451,232 | Direct | |
| Nov 16, 2023 | Common Stock | SSaleDisposed | −16,415 | $60.20 | −$988,183 | 434,817 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.